Description

6-Chloro-9-[(3-Methoxyphenyl)Methyl]-3,4-Dimethyl-8,10-Dihydropyrano[2,3-F][1,3]Benzoxazin-2-One is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is critical for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents. It is primarily sought by pharmaceutical R&D laboratories, contract research organizations (CROs), and fine chemical manufacturers engaged in developing new active pharmaceutical ingredients (APIs).

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new chemical entities.
• API Development: Serves as a precursor in the multi-step synthesis of complex Active Pharmaceutical Ingredients (APIs).
• Biochemical Research: Potential use as a tool compound or probe for studying biological mechanisms and enzyme interactions.
• Contract Manufacturing: Supplied to CDMOs (Contract Development and Manufacturing Organizations) for custom synthesis projects.
• Academic Research: Utilized in university and institutional labs for advanced organic synthesis and heterocyclic chemistry studies.

Basic Information

Product Name	6-Chloro-9-[(3-Methoxyphenyl)Methyl]-3,4-Dimethyl-8,10-Dihydropyrano[2,3-F][1,3]Benzoxazin-2-One
CAS No.	853893-15-9
Molecular Formula	C22H20ClNO4
Molecular Weight	397.85 g/mol
Synonyms	6-Chloro-9-[(3-methoxyphenyl)methyl]-3,4-dimethyl-8,10-dihydropyrano[2,3-f][1,3]benzoxazin-2-one; Pyrano[2,3-f][1,3]benzoxazin-2-one, 6-chloro-9-[(3-methoxyphenyl)methyl]-3,4-dihydro-8,10-dimethyl-; CAS 853893-15-9; 853893-15-9; 6-Chloro-9-(3-methoxybenzyl)-3,4-dimethyl-8,10-dihydropyrano[2,3-f][1,3]benzoxazin-2-one
EINECS	Contact for details

Quality Control

Our 6-Chloro-9-[(3-Methoxyphenyl)Methyl]-3,4-Dimethyl-8,10-Dihydropyrano[2,3-F][1,3]Benzoxazin-2-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) with full traceability are provided for every shipment.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, well-ventilated area at a controlled room temperature (15-25°C). Keep away from incompatible materials. For long-term storage, consider storage under an inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm
Single Unknown Impurity (HPLC)	≤ 0.5%
Total Impurities (HPLC)	≤ 2.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.